Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Verdonk

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Molecular Graphics & Modelling|June 12, 2003
A web-based platform for virtual screeningPaul Watson, Marcel Verdonk, Michael J Hartshorn
Current Opinion in Chemical Biology|September 14, 2007
Fragment-based screening using X-ray crystallography and NMR spectroscopyHarren Jhoti, Anne Cleasby, Marcel Verdonk, et al.
Current Topics in Medicinal Chemistry|August 19, 2007
A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical developmentAdrian L Gill, Marcel Verdonk, Robert G Boyle, et al.
Bioinformatics (Oxford, England)|June 27, 2025
Mapping the space of protein binding sites with sequence-based protein language modelsTuğçe Oruç, Maria Kadukova, Thomas G Davies, et al.
Journal of Medicinal Chemistry|March 19, 2008
Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaborationJohn J Caldwell, Thomas G Davies, Alastair Donald, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Molecular Graphics & Modelling|June 12, 2003
A web-based platform for virtual screeningPaul Watson, Marcel Verdonk, Michael J Hartshorn
Current Opinion in Chemical Biology|September 14, 2007
Fragment-based screening using X-ray crystallography and NMR spectroscopyHarren Jhoti, Anne Cleasby, Marcel Verdonk, et al.
Current Topics in Medicinal Chemistry|August 19, 2007
A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical developmentAdrian L Gill, Marcel Verdonk, Robert G Boyle, et al.
Bioinformatics (Oxford, England)|June 27, 2025
Mapping the space of protein binding sites with sequence-based protein language modelsTuğçe Oruç, Maria Kadukova, Thomas G Davies, et al.
Journal of Medicinal Chemistry|March 19, 2008
Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaborationJohn J Caldwell, Thomas G Davies, Alastair Donald, et al.
Pageof 1